MDL-29951
MDL-29951 is a selective glycine-site antagonist of the NMDA receptor. It is a valuable research tool for investigating glutamatergic neurotransmission in models of neurological disorders, applicable in both in vitro binding assays and in vivo studies.
Product Specifications
CAS Number
130798-51-5
Product Name Alternative
Inhibit, Inhibitor, Ionotropic glutamate receptors, NMDA receptor, MDL 29951, MDL29951, MDL-29951, iGluR
Field of Research
Immunology & Inflammation, Neuroscience
Purity
>98%
Bioactivity
GPR17 agonist
Form
Powder
Solubility
Soluble in DMSO (up to 15 mg/ml with warming) or in Ethanol (up to 10 mg/ml) .
Smiles
OC (=O) CCc1c ([nH]c2cc (Cl) cc (Cl) c12) C (O) =O
Molecular Formula
C12H9Cl2NO4
Molecular Weight
302.11
Storage Conditions
RT
Notes
For research use only.
Other Product Names
3- (2-Carboxy-4,6-dichloroindol-3-yl) propionic acid
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
SR309807 1 Kit
PTPLAD1 (HACD3) Human siRNA Oligo Duplex (Locus ID 51495)
Sign In for Pricing
View Details 
MBS6175129-01 0.1 mL
IRAK4 (Interleukin-1 Receptor-Associated Kinase 4, IPD1, NY-REN-64, REN64) (FITC)
Sign In for Pricing
View Details MBS6175129-02 5x 0.1 mL
IRAK4 (Interleukin-1 Receptor-Associated Kinase 4, IPD1, NY-REN-64, REN64) (FITC)
Sign In for Pricing
View Details